The successful research and development of Geifu completely subvert the traditional trauma treatment methods, leaping from the original "passive repair" to the precise "active repair". It can not only accelerate the start of the body's wound repair mechanism, actively promote tissue repair, greatly shorten the healing time, but also prevent scar formation, repair the damaged physiological function, and significantly improve the speed and quality of wound healing. In the field of trauma repair (e.g. Trauma, burn and scald, difficult healing wounds, surgery, plastic beauty, national defense, etc.) has a very wide range of applications, at present, the company sales network has been all over the country, autonomous regions, fill the jurisdiction of the city, cover has become more than 1300 hospitals in the country routinely used products, and with its significant effect has been highly recognized by the majority of medical workers and patients.

Science and technology is the primary productivity, and new product development is the inexhaustible driving force for the development of enterprises (especially pharmaceutical enterprises). Longtide Pharmaceutical adheres to the enterprise spirit of "innovation, development and excellence", relies on Jinan University, and has horizontal cooperation with many well-known research institutes at home and abroad, such as Chinese Academy of Sciences, Peking University, Sun Yat-sen University, Wenzhou Medical University and the University of Hong Kong. Five research platforms have been established, including gene engineering, protein engineering, stem cell engineering, preclinical safety evaluation of drugs, and bio-cosmetic detection. Based on the geographical, financial and institutional advantages of the Pearl River Delta, and adhering to the corporate mission of "reorganizing life elements and serving public health", the research platform has been built into a bioengineering pilot development center, a drug preclinical safety evaluation center and a biocosmetic testing center in South China.

At the same time, the company hired Academician Yang Shengli, Academician Wang Zhengguo, Academician Cheng Tianmin, Academician Fu Xiaobing and other top experts at home and abroad to form the research and development expert Committee, with Professor Li Xiaokun, chief scientist of Lantide Pharmaceutical, as the research president. And has in line with GMP standards of bioengineering pharmaceutical pilot workshop, genetic engineering laboratory, biological cosmetics testing laboratory, standard animal laboratory, for the company to continue to launch new products to lay a solid foundation.